Skip to main content
SpringerLink
Log in

Hydroxyäthylstärke

Hydroxyethyl starch

  • Leserbriefe
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Barron ME, Wilkes MM, Narvickis RJ (2004) A systematic review of the comparative safety of colloids. Arch Surg 193:552–563

    Article  Google Scholar 

  2. Beekes M (2010) Die variante Creutzfeldt-Jakob-Krankheit (vCJK) – Epidemiologie und Schutzmaßnahmen gegen eine Übertragung von Mensch zu Mensch. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53:597–605

    Article  PubMed  CAS  Google Scholar 

  3. Bunn F, Trivedi D (2012) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 7:CD001319

    PubMed  Google Scholar 

  4. Grobben AH, Steele PJ, Somerville RA, Taylor DM (2006) Inactivation of BSE infectivity on chips of bone by autoclaving during the manufacture of gelatine. Vet Rec 158:94–96

    Article  PubMed  CAS  Google Scholar 

  5. Hueston WD (2013) BSE and variant CJD: emerging science, public pressure and the vagaries of policy-making. Prev Vet Med 109:179–184

    Article  PubMed  Google Scholar 

  6. Jacob M, Annaheim S, Boutellier U et al (2012) Haematocrit is invalid for estimating red cell volume: a prospective study in male volunteers. Blood Transfus 10:471–479

    PubMed  Google Scholar 

  7. Jacob M, Conzen P, Finsterer U et al (2007) Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings. J Appl Physiol 102:1235–1242

    Article  PubMed  CAS  Google Scholar 

  8. Kretzschmar H, Tatzelt J (2013) Prion disease: a tale of folds and strains. Brain Pathol 23:321–332

    Article  PubMed  Google Scholar 

  9. Laxenaire MC, Charpentier C, Feldman L (1994) Réactions anaphylactoïdes aux substituts colloïdaux du plasma: Incidence, facteurs de risque, mécanismes. Enquête prospective multicentrique française. Ann Fr Anesth Réanim 13:301–310

    Article  PubMed  CAS  Google Scholar 

  10. Lobo DN, Stanga Z, Aloysius MM et al (2010) Effect of volume loading with 1 l intravenous infusions of 0.9  % saline, 4  % succinylated gelatine (Gelofusine) and 6 % hydroxyl-ethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 38:464–470

    Article  PubMed  CAS  Google Scholar 

  11. Marx G, Cobas Meyer M, Schuerholz T et al (2002) Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med 28:629–635

    Article  PubMed  CAS  Google Scholar 

  12. Perel P, Roberts I, Ker K (2013) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2:CD000567

    PubMed  Google Scholar 

  13. o A (1992) Public health issues related to animal and human spongiform encephalopathies Memorandum from a WHO meeting. Bull World Health Organ 70:183–190

    Google Scholar 

  14. Rehm M (2013) Anwendungsbeschränkung für Hydroxyäthylstärke – Hintergründe und alternative Konzepte. Anaesthesist 62:644–655

    Article  PubMed  CAS  Google Scholar 

  15. Rehm M, Orth VH, Weninger E et al (2001) Acute „normovolemic“ hemodilution with 3.5 % polygel (Haemaccel) for patients in the Wertheim-Meigs-operation. Blood loss of 87 % blood volume without perioperative blood transfusion. Anaesthesist 50:580–584

    Article  PubMed  CAS  Google Scholar 

  16. Ring J, Meßmer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 466–469

  17. Stellungnahme des BgVV zu einer Anfrage des Abgeordneten Dr. Wolfgang Wodarg vom 12. August 1996 BSE – Anforderungen an die Gelatineherstellung. http://www.bfr.bund.de/cm/343/bse_anforderungen_an_die_gelatineherstellung.pdf

  18. Thomas-Rueddel DO, Vlasakov V, Reinhart K et al (2012) Safety of gelatin for volume resuscitation – a systematic review and meta-analysis. Intensive Care Med 38:1134–1142

    Article  PubMed  CAS  Google Scholar 

  19. Vincent JL, Wilkes MM, Navickis RJ (2003) Safety of human albumin – serious adverse events reported worldwide in 1998–2000. Br J Anaesth 91:625–630

    Article  PubMed  CAS  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. M. Rehm leitet aktuell 2 klinische Studien, von denen eine von CSL Behring, eine von Fresenius Kabi unterstützt wird. Er hat in den letzten 2 Jahren von CSL Behring und Fresenius Kabi Reisekosten und Honorare für Vorträge erhalten.

Author information

Consortia

-

Rights and permissions

Reprints and permissions

About this article

Cite this article

-. Hydroxyäthylstärke. Anaesthesist 62, 926–930 (2013). https://doi.org/10.1007/s00101-013-2261-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-013-2261-z

Search

Navigation